Lipoprotein(a) and the risk of cardiovascular disease in the European population: results from the BiomarCaRE consortium

As promising compounds to lower Lipoprotein(a) (Lp(a)) are emerging, the need for a precise characterization and comparability of the Lp(a)-associated cardiovascular risk is increasing. Therefore, we aimed to evaluate the distribution of Lp(a) concentrations across the European population, to charac...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	European heart journal Ročník 38; číslo 32; s. 2490
Hlavní autoři:	Waldeyer, Christoph, Makarova, Nataliya, Zeller, Tanja, Schnabel, Renate B, Brunner, Fabian J, Jørgensen, Torben, Linneberg, Allan, Niiranen, Teemu, Salomaa, Veikko, Jousilahti, Pekka, Yarnell, John, Ferrario, Marco M, Veronesi, Giovanni, Brambilla, Paolo, Signorini, Stefano G, Iacoviello, Licia, Costanzo, Simona, Giampaoli, Simona, Palmieri, Luigi, Meisinger, Christa, Thorand, Barbara, Kee, Frank, Koenig, Wolfgang, Ojeda, Francisco, Kontto, Jukka, Landmesser, Ulf, Kuulasmaa, Kari, Blankenberg, Stefan
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	England 21.08.2017
Témata:	Adult Biomarkers - metabolism Cardiovascular Diseases - etiology Cardiovascular Diseases - mortality Europe - epidemiology Female Humans Kaplan-Meier Estimate Lipoprotein(a) - metabolism Lipoprotein(a) - physiology Male Middle Aged Prognosis Prospective Studies Residence Characteristics - statistics & numerical data Risk Assessment BiomarCaRE (Biomarker for Cardiovascular Risk Assessment in Europe) Lipoprotein(a) MORGAM (MONICA Risk Genetics Archiving and Monograph) Mortality Cardiovascular risk
ISSN:	1522-9645, 1522-9645
On-line přístup:	Zjistit podrobnosti o přístupu
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!